Celgene (celg) Stock Falls After Mixed Second-quarter Earnings

(Update 9:45 a.m.): Updated with conference call information and stock price. NEW YORK (TheStreet) -- Celgene fell 2.01% to $87.33 in early morning trading on Thursday after the biotechnology company reported mixed second-quarter results. Celgene reported a year-over-year increase in net profit to $597.8 million, or 72 cents a share, from $478.1 million, or 56 cents a share.

BING NEWS:
  • Silgan Holdings reports mixed Q1 results; initiates Q2 and reaffirms FY24 outlook
    Capital expenditures are expected to be approximately $240 million in 2024. For the second quarter of 2024, the Company expects low to mid single digit volume growth in the Dispensing and Specialty ...
    05/1/2024 - 1:01 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News